Middle East And Africa Diabetes Devices Market

Market Overview

During the projected period, the Middle East And Africa Diabetes Devices Market is expected to increase at a CAGR of 7.4 %, reaching a total value of 1,765 million USD in 2030.

Diabetes occurs when the pancreas is unable to create insulin from the blood. Increased blood sugar levels induce untreated diabetes. Diabetes drugs are used to treat diabetes in specific. The purpose of diabetic treatment is to raise blood glucose levels. Diabetes care gadgets are used to monitor blood glucose levels in diabetics. A continuous glucose monitor (CGM) is a medical device that tracks and monitors the blood glucose levels of diabetes patients throughout the day. This wearable device will benefit those with diabetes since it can help them manage their glucose levels. Diabetic monitoring equipment includes ketone metres, blood glucose metres, continuous glucose metres, insulin pumps, smart insulin pens, and diabetes management software. Glucose monitoring devices help patients maintain and control their glucose levels, improving their health.

In the Middle East and Africa, self-monitoring with a glucometer is more acceptable due to the high costs involved with continuous glucose monitoring (CGM). These devices aid in the early detection of hypoglycaemia and hyperglycaemia, which drive the glucose monitoring industry.

Get more information on this report Download Sample Report

Market Dynamics

Key Market Drivers

• Lazy lifestyle and Food habits

  Increased calorie consumption (high-fat diet) and lack of exercise, as well as genetic and environmental factors, all have a role in sugar level regulation in type 2 diabetes. All of these variables contribute to insulin-related issues, which lead to late-onset type 2 diabetes. With these factors, the number of people having diabetes will increase and the demand for these devices will also increase.

• Awareness about diabetes care

  People nowadays are more aware and concerned about diabetes and its implications and the case in same in the Middle East and Africa countries. Although, in some African countries of Africa there is still scope for increasing literacy and awareness still this increasing or rising awareness about diabetes care will enhance the demand for these devices.

Key Market Restraints

• Low medical literacy rate and awareness

  A large portion of the population in the Asia Pacific region comes from rural areas, where illiteracy rates are extremely high, as well as the level, quality, and awareness of medical facilities. As a result, many people are unaware of these devices and even of this disease, which may stymie market growth in this region.

• High Cost of Medical Devices

  It is a well-known fact that many African countries are economically not stable and still trying to get develop. Per capita income in many of the African countries is not enough and hence diabetic devices are not affordable easily for a significant proportion of the population which can serve as a restraint for the market growth in the African region

Segmental Analysis

The Middle East And Africa Diabetes Devices Market region segment has been categorised by type, distribution channel, and application.

According to type, the diabetes devices market is divided into blood glucose monitoring devices and insulin administration devices. The insulin delivery devices sector is likely to lead the market, with a projected value of USD 30,412.19 million by 2030, representing a 7.62% CAGR over the forecast period.

The expanding number of rules and approvals for technological developments in insulin delivery devices such as insulin pens, insulin pumps, jet injectors, and other devices are some of the key driving factors for demand for insulin delivery devices. The growing acceptability of insulin patches and smart insulin pumps for diabetes self-management is one of the factors boosting demand for insulin delivery devices.

Based on the distribution channel

the diabetic devices market has been divided into hospitals, retail pharmacies, diabetes clinics/centres, internet pharmacies, and others. The retail pharmacies sector is estimated to lead the market, with revenues of USD 11,491.59 million by 2030, representing a CAGR of 6.92% over the forecast period. Some of the reasons projected to promote the growth of the retail sales segment over the projection period include the rising penetration of private-label products in retail stores at lower prices.

Based on application

the diabetic devices market has been divided into hospitals, home care, and diagnostic centres. The hospital's category is likely to lead the market, with revenues of USD 19,845.68 million expected by 2030, representing a CAGR of 6.42% during the forecast period. Diabetic people are increasingly being admitted to hospitals.

Type 1 diabetes patients had longer hospital stays, a higher death rate, and more complications than type 2 diabetes patients. Type 1 diabetes patients are administered insulin to prevent ketoacidosis, although they have a higher rate of hyperglycaemia. As a result, an increase in the number of type 1 diabetes patients in hospitals, as well as an increase in the demand for continuous blood glucose monitoring, are two factors pushing up the demand.

Regional Analysis

During the projected period, the Middle East And Africa Diabetes Devices Market is expected to increase at a CAGR of 7.4 %, reaching a total value of 1,765 million USD in 2030. In the Middle East and Africa, self-monitoring with a glucometer is more acceptable due to the high costs involved with continuous glucose monitoring (CGM). These devices aid in the early detection of hypoglycaemia and hyperglycaemia, which drive the glucose monitoring industry. Test strips account for 45% of the market in the Middle East and Africa, generating USD 136 million in revenue. When purchasing blood glucose test strips, the cost is typically a major consideration. Although some nations fund prescription test strips, the vast majority of patients must pay for them out of cash. Over the last decade, the number of diabetic patients in Africa has increased. Africa's total diabetes-related health spending is close to USD 9,500 million, with the figure predicted to nearly treble by 2045.

In the Middle East and Africa Blood Glucose Monitoring Market, Saudi Arabia and Iran together accounted for more than half of the market. Saudi Arabia has a 36% market share in the Middle East and Africa Blood Glucose Monitoring Market, followed by Iran and others. The rising prevalence of diabetes in Saudi Arabia has resulted in increased sales of blood glucose monitoring devices. Saudi Arabia has a high diabetes prevalence, with 24%, Kuwait at 23%, Bahrain at 22%, Qatar at 20%, and the United Arab Emirates at 19%. Israel is also experiencing encouraging growth in the market growth is the past few years due to increasing in the diabetic population in the market and increased awareness than before.

Recent Developments

• In 2021, the Saudi Ministry of Health and Saudi Endocrine Society is planning to mandate each hospital institution to have Continuous Glucose Monitoring Devices and Insulin Pump Devices training programs and increase the number of doctors and trainers by end of 2021.

Middle East And Africa Diabetes Devices Market Segmentation

By Type

• Blood Glucose Monitoring Devices
• Insulin Delivery Devices

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Diabetes Clinics/Centers
• Online Pharmacies
• Others

By Application

• Hospitals
• Homecare
• Diagnostics Centers

By Country

• United Arab Emirates
• Saudi Arabia
• Qatar
• Kuwait
• Oman
• Israel
• Egypt
• South Africa
• Nigeria
• Kenya
• Rest of Middle East And Africa